Venn Life Sciences has recently acquired two European CROs, CRM Clinical Trials and Medevol Clinical Services. CRM is a full-service CRO based in Rheinbach, Germany, specializing in Phases II-IV, with expertise in dermatology, pneumology and urology, as well as conducting trials in the field of sports medicine and non-interventional studies. CRM also serves the Austrian and Italian regions. CRM’s services include initial and ongoing training for study nurses, investigators and trial teams in the areas of quality, planning and monitoring of clinical studies.
Medevol, based in Belfast, conducts full-service studies across Phases II – IV, with therapeutic experience across a broad range of indications. Medevol also provides contract staffing solutions to manage different levels of resourcing needs throughout the clinical trial process.
Tony Richardson, chief executive officer of Venn, said, “The addition of these two offices to Venn’s European operations further aligns our actions to our overall strategy of becoming a leading mid-sized European CRO. The skills and talent that we are adding to our company enhance our reputation as a CRO that stays close to its clients, guiding them through the often complicated process of conducting trials across Europe. We as a company are also looking at adding to these acquisitions over the coming months and increasing our office locations across Europe”